Related references
Note: Only part of the references are listed.Genomic Analysis of Hepatoblastoma Identifies Distinct Molecular and Prognostic Subgroups
Pavel Sumazin et al.
HEPATOLOGY (2017)
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation
Jean-Charles Nault et al.
GASTROENTEROLOGY (2017)
Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity
Agrin Moeini et al.
JOURNAL OF HEPATOLOGY (2017)
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2017)
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2017)
Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma
Sara Torrecilla et al.
JOURNAL OF HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells
Zhipeng Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration
Alexander Raven et al.
NATURE (2017)
LIVER CANCER Translating '-omics' results into precision medicine for hepatocellular carcinoma
Daniela Sia et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation
Eric C. Sorenson et al.
PLOS ONE (2017)
Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
Mei Zhou et al.
NATURE COMMUNICATIONS (2017)
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Apinya Jusakul et al.
CANCER DISCOVERY (2017)
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
Xiao-Xiao Ding et al.
ONCOTARGET (2017)
Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1-and TGF-β/Smad-regulated liver cancer stem cell-like cells
Wei Xia et al.
ONCOTARGET (2017)
Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma
Timothy A. Dinh et al.
SCIENTIFIC REPORTS (2017)
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells
Krishna S. Tummala et al.
CELL REPORTS (2017)
Molecular Pathogenesis of Liver Cancer
Mehmet Ozturk et al.
JOURNAL OF GASTROINTESTINAL CANCER (2017)
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Jittiporn Chaisaingmongkol et al.
CANCER CELL (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
Agrin Moeini et al.
CLINICAL CANCER RESEARCH (2016)
Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity
Jie-Yi Shi et al.
ONCOTARGET (2016)
The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma
Jing Luo et al.
ONCOTARGET (2016)
A genomic case study of mixed fibrolamellar hepatocellular carcinoma
O. L. Griffith et al.
ANNALS OF ONCOLOGY (2016)
p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
Atsushi Umemura et al.
CANCER CELL (2016)
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition
Shigeki Nakagawa et al.
CANCER CELL (2016)
Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma
Shinichi Yachida et al.
CANCER CELL (2016)
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Elizabeth C. Townsend et al.
CANCER CELL (2016)
Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line
Phyllis F. Y. Cheung et al.
CANCER CELL INTERNATIONAL (2016)
Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma
Ruidong Xue et al.
GASTROENTEROLOGY (2016)
Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma
Talya L. Dayton et al.
GENES & DEVELOPMENT (2016)
Sox9 Regulates Self-Renewal and Tumorigenicity by Promoting Symmetrical Cell Division of Cancer Stem Cells in Hepatocellular Carcinoma
Chungang Liu et al.
HEPATOLOGY (2016)
Patient- Derived Mouse Xenografts From Pediatric Liver Cancer Predict Tumor Recurrence and Advise Clinical Management
Delphine Nicolle et al.
HEPATOLOGY (2016)
Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma
Takayuki Shimizu et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2016)
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer
Beatrice Bissig-Choisat et al.
JOURNAL OF HEPATOLOGY (2016)
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer
Akihiro Fujimoto et al.
NATURE GENETICS (2016)
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer
Daniel Dauch et al.
NATURE MEDICINE (2016)
lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal
Pingping Zhu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma
Kevin M. Riggle et al.
PEDIATRIC BLOOD & CANCER (2016)
Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma
Kevin M. Riggle et al.
PEDIATRIC RESEARCH (2016)
Genetic alterations in hepatocellular carcinoma: An update
Zhao-Shan Niu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells
Pingping Zhu et al.
NATURE COMMUNICATIONS (2016)
TERT promoter mutations in primary liver tumors
Jean-Charles Nault et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal
Pingping Zhu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
MEK1 signaling promotes self-renewal and tumorigenicity of liver cancer stem cells via maintaining SIRT1 protein stabilization
Jiamin Cheng et al.
ONCOTARGET (2016)
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
Marta Anna Kowalik et al.
ONCOTARGET (2016)
Prognostic value of DNA repair based stratification of hepatocellular carcinoma
Zhuo Lin et al.
SCIENTIFIC REPORTS (2016)
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation
Marie-Claude Gingras et al.
CELL REPORTS (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin
Sarah A. Comerford et al.
JCI INSIGHT (2016)
Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer
Joan Font-Burgada et al.
CELL (2015)
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Meritxell Huch et al.
CELL (2015)
The Long Noncoding RNA IncTCF7 Promotes Self-Renewal of Human Liver Cancer Stem Cells through Activation of Wnt Signaling
Yanying Wang et al.
CELL STEM CELL (2015)
Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma
Takayuki Kawai et al.
CLINICAL CANCER RESEARCH (2015)
Evidence of cell-fate conversion from hepatocytes to cholangiocytes in the injured liver: in-vivo genetic lineage-tracing approaches
Atsushi Suzuki
CURRENT OPINION IN GASTROENTEROLOGY (2015)
Unique Genomic Profile of Fibrolamellar Hepatocellular Carcinoma
Helena Cornella et al.
GASTROENTEROLOGY (2015)
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
Luke Boulter et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment
Xueru Mu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells
Pingping Zhu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Liver cancer: Approaching a personalized care
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2015)
Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation
Oriana Miltiadous et al.
JOURNAL OF HEPATOLOGY (2015)
DNAJB1-PRKACA is specific for fibrolamellar carcinoma
Rondell P. Graham et al.
MODERN PATHOLOGY (2015)
Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver
Bruce Wang et al.
NATURE (2015)
Hepatic progenitor cells of biliary origin with liver repopulation capacity
Wei-Yu Lu et al.
NATURE CELL BIOLOGY (2015)
Genomic spectra of biliary tract cancer
Hiromi Nakamura et al.
NATURE GENETICS (2015)
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
Jean-Charles Nault et al.
NATURE GENETICS (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Contribution of Mature Hepatocytes to Biliary Regeneration in Rats with Acute and Chronic Biliary Injury
Ya-Hui Chen et al.
PLOS ONE (2015)
Transcriptomic characterization of fibrolamellar hepatocellular carcinoma
Elana P. Simon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Annexin A3 as a Potential Target for Immunotherapy of Liver Cancer Stem-Like Cells
Qiu-Zhong Pan et al.
STEM CELLS (2015)
Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells
Tsunekazu Oikawa et al.
NATURE COMMUNICATIONS (2015)
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity
Akihiro Fujimoto et al.
NATURE COMMUNICATIONS (2015)
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
Daniela Sia et al.
NATURE COMMUNICATIONS (2015)
The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients
David G. Darcy et al.
ONCOTARGET (2015)
SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma
Gang Deng et al.
ONCOTARGET (2015)
Bile acids induce hepatic differentiation of mesenchymal stem cells
Iris Sawitza et al.
SCIENTIFIC REPORTS (2015)
YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression
Julien Fitamant et al.
CELL REPORTS (2015)
Intratumor Heterogeneity in Hepatocellular Carcinoma
Juliane Friemel et al.
CLINICAL CANCER RESEARCH (2015)
Genomic analysis of fibrolamellar hepatocellular carcinoma
Lei Xu et al.
HUMAN MOLECULAR GENETICS (2015)
Functional and genetic deconstruction of the cellular origin in liver cancer
Jens U. Marquardt et al.
NATURE REVIEWS CANCER (2015)
Molecular classification of hepatocellular carcinoma: potential therapeutic implications
Nicolas Goossens et al.
HEPATIC ONCOLOGY (2015)
SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis
Hyunjin Park et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2015)
Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells
Xin Wang et al.
ACS NANO (2014)
Hepatocytes, Rather than Cholangiocytes, Can Be the Major Source of Primitive Ductules in the Chronically Injured Mouse Liver
Sayaka Sekiya et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
Xin Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Genomic Profiling of Hepatocellular Adenomas Reveals Recurrent FRK-Activating Mutations and the Mechanisms of Malignant Transformation
Camilla Pilati et al.
CANCER CELL (2014)
Cell Lineage Tracing Reveals a Biliary Origin of Intrahepatic Cholangiocarcinoma
Rachel V. Guest et al.
CANCER RESEARCH (2014)
β-Catenin Activation in a Novel Liver Progenitor Cell Type Is Sufficient to Cause Hepatocellular Carcinoma and Hepatoblastoma
Sharada Mokkapati et al.
CANCER RESEARCH (2014)
Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24
Allan Yi Liu et al.
CARCINOGENESIS (2014)
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer
Darjus F. Tschaharganeh et al.
CELL (2014)
Hippo Pathway Activity Influences Liver Cell Fate
Dean Yimlamai et al.
CELL (2014)
Adult Hepatocytes Are Generated by Self-Duplication Rather than Stem Cell Differentiation
Kilangsungla Yanger et al.
CELL STEM CELL (2014)
Stem/Progenitor Cells in Liver Development, Homeostasis, Regeneration, and Reprogramming
Atsushi Miyajima et al.
CELL STEM CELL (2014)
Bipotential Adult Liver Progenitors Are Derived from Chronically Injured Mature Hepatocytes
Branden D. Tarlow et al.
CELL STEM CELL (2014)
Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
Huiping Gao et al.
CLINICAL CANCER RESEARCH (2014)
Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
Shanshan Wan et al.
GASTROENTEROLOGY (2014)
Fibroblast Growth Factor Receptor 2 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Cholangiocarcinoma
Yasuhito Arai et al.
HEPATOLOGY (2014)
Transcriptional Profiling of Pure Fibrolamellar Hepatocellular Carcinoma Reveals an Endocrine Signature
Gabriel G. Malouf et al.
HEPATOLOGY (2014)
Exome Sequencing of Hepatoblastoma Reveals Novel Mutations and Cancer Genes in the Wnt Pathway and Ubiquitin Ligase Complex
Deshui Jia et al.
HEPATOLOGY (2014)
Clonal Tracing of Sox9+ Liver Progenitors in Mouse Oval Cell Injury
Branden D. Tarlow et al.
HEPATOLOGY (2014)
Telomerase Reverse Transcriptase Promoter Mutation Is an Early Somatic Genetic Alteration in the Transformation of Premalignant Nodules in Hepatocellular Carcinoma on Cirrhosis
Jean Charles Nault et al.
HEPATOLOGY (2014)
Sry HMG Box Protein 9-positive (Sox9+) Epithelial Cell Adhesion Molecule-negative (EpCAM-) Biphenotypic Cells Derived from Hepatocytes Are Involved in Mouse Liver Regeneration
Naoki Tanimizu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Hepatic stellate cells contribute to progenitor cells and liver regeneration
Claus Kordes et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits
Jens U. Marquardt et al.
JOURNAL OF HEPATOLOGY (2014)
The genomic landscape of hepatoblastoma and their progenies with HCC-like features
Melanie Eichenmüller et al.
JOURNAL OF HEPATOLOGY (2014)
The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
Sha Sha Zeng et al.
JOURNAL OF HEPATOLOGY (2014)
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
Supriya K. Saha et al.
NATURE (2014)
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Yasushi Totoki et al.
NATURE GENETICS (2014)
Exploration of liver cancer genomes
Tatsuhiro Shibata et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma
Joshua N. Honeyman et al.
SCIENCE (2014)
The CD133+CD44+ Precancerous Subpopulation of Oval Cells Is a Therapeutic Target for Hepatocellular Carcinoma
Yun-Wen Zheng et al.
STEM CELLS AND DEVELOPMENT (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
Michele Simbolo et al.
ONCOTARGET (2014)
Evidence against a Stem Cell Origin of New Hepatocytes in a Common Mouse Model of Chronic Liver Injury
Johanna R. Schaub et al.
CELL REPORTS (2014)
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
Steffen Zender et al.
CANCER CELL (2013)
1B50-1, a mAb Raised against Recurrent Tumor Cells, Targets Liver Tumor-Initiating Cells by Binding to the Calcium Channel α2δ1 Subunit
Wei Zhao et al.
CANCER CELL (2013)
Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis
Yu-Cheng Ma et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
Jean-Charles Nault et al.
GASTROENTEROLOGY (2013)
Modeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types
Agnes Holczbauer et al.
GASTROENTEROLOGY (2013)
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia et al.
GASTROENTEROLOGY (2013)
Robust cellular reprogramming occurs spontaneously during liver regeneration
Kilangsungla Yanger et al.
GENES & DEVELOPMENT (2013)
Discrete nature of EpCAM+ and CD90+cancer stem cells in human hepatocellular carcinoma
Taro Yamashita et al.
HEPATOLOGY (2013)
CD133 silencing inhibits sternness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stern cells
Xi Lan et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Differentiation of progenitors in the liver: a matter of local choice
Luke Boulter et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Meritxell Huch et al.
NATURE (2013)
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers
Waraporn Chan-on et al.
NATURE GENETICS (2013)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Yuchen Jiao et al.
NATURE GENETICS (2013)
Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma
Kol Jia Yong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target
Anna Saborowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Efficacy of Using Cancer Stem Cell Markers in Isolating and Characterizing Liver Cancer Stem Cells
George S. Wilson et al.
STEM CELLS AND DEVELOPMENT (2013)
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
Jean Charles Nault et al.
NATURE COMMUNICATIONS (2013)
Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma
Sorin Armeanu-Ebinger et al.
ONCOIMMUNOLOGY (2013)
Increased CD13 Expression Reduces Reactive Oxygen Species, Promoting Survival of Liver Cancer Stem Cells via an Epithelial-Mesenchymal Transition-like Phenomenon
Ho Min Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma
Lian Shu Piao et al.
CANCER LETTERS (2012)
CD44s Regulates the TGF-β-Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
Kosuke Mima et al.
CANCER RESEARCH (2012)
Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways
Cedric Coulouarn et al.
CARCINOGENESIS (2012)
The critical role of CD133+CD44+/high tumor cells in hematogenous metastasis of liver cancers
Ying Hou et al.
CELL RESEARCH (2012)
CD133+liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling
Kwan Ho Tang et al.
HEPATOLOGY (2012)
CD133+EpCAM+ Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells
Yi Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
OV6+ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma
Wen Yang et al.
JOURNAL OF HEPATOLOGY (2012)
Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease
Luke Boulter et al.
NATURE MEDICINE (2012)
Gene Expression Profiling of Liver Cancer Stem Cells by RNA-Sequencing
David W. Y. Ho et al.
PLOS ONE (2012)
EpCAM and its potential role in tumor-initiating cells
Sannia Imrich et al.
CELL ADHESION & MIGRATION (2012)
CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
Terence Kin Wah Lee et al.
CELL STEM CELL (2011)
Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2011)
miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1
Stephanie Ma et al.
CELL STEM CELL (2010)
Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma
Zheng Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
CD13 is a therapeutic target in human liver cancer stem cells
Naotsugu Haraguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma
Benoit Terris et al.
JOURNAL OF HEPATOLOGY (2010)
Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation
Stephen C. Ward et al.
MODERN PATHOLOGY (2010)
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
Yujin Hoshida et al.
CANCER RESEARCH (2009)
An Akt/Hypoxia-Inducible Factor-1α/Platelet-Derived Growth Factor-BB Autocrine Loop Mediates Hypoxia-Induced Chemoresistance in Liver Cancer Cells and Tumorigenic Hepatic Progenitor Cells
Chi Keung Lau et al.
CLINICAL CANCER RESEARCH (2009)
EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
Taro Yamashita et al.
GASTROENTEROLOGY (2009)
Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer
Stefano Cairo et al.
CANCER CELL (2008)
Significance of CD90+ cancer stem cells in human liver cancer
Zhen Fan Yang et al.
CANCER CELL (2008)
EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma
Taro Yamashita et al.
CANCER RESEARCH (2008)
Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells
Wen Yang et al.
CANCER RESEARCH (2008)
Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
W. Song et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations
Stephanie Ma et al.
MOLECULAR CANCER RESEARCH (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
S. Ma et al.
ONCOGENE (2008)
Activation of hepatic stem cell marker EpCAM by Wnt-β-catenin signaling in hepatocellular carcinoma
Taro Yamashita et al.
CANCER RESEARCH (2007)
Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation
Tetsuhiro Chiba et al.
GASTROENTEROLOGY (2007)
Identification and characterization of tumorigenic liver cancer stem/progenitor cells
Stephanie Ma et al.
GASTROENTEROLOGY (2007)
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity
Shengyong Yin et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells
Atsushi Suetsugi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?
Stefan Aretz et al.
PEDIATRIC BLOOD & CANCER (2006)
Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties
Tetsuhiro Chiba et al.
HEPATOLOGY (2006)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
JS Lee et al.
NATURE MEDICINE (2006)
Characterization of a side population of cancer cells from human gastrointestinal system
Naotsugu Haraguchi et al.
STEM CELLS (2006)
Elevated expression of Wnt antagonists is a common event in hepatoblastomas
A Koch et al.
CLINICAL CANCER RESEARCH (2005)
Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas
A Koch et al.
JOURNAL OF PATHOLOGY (2004)
Share Paper
